0 false false false false false false false false false false true false false false false false false No description of principal activity 2025-03-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 11821066 2025-03-01 2026-02-28 11821066 2026-02-28 11821066 2025-02-28 11821066 2024-03-01 2025-02-28 11821066 2025-02-28 11821066 2024-02-29 11821066 bus:Director1 2025-03-01 2026-02-28 11821066 core:WithinOneYear 2026-02-28 11821066 core:WithinOneYear 2025-02-28 11821066 bus:Micro-entities 2025-03-01 2026-02-28 11821066 bus:AuditExempt-NoAccountantsReport 2025-03-01 2026-02-28 11821066 bus:SmallCompaniesRegimeForAccounts 2025-03-01 2026-02-28 11821066 bus:PrivateLimitedCompanyLtd 2025-03-01 2026-02-28 11821066 bus:FullAccounts 2025-03-01 2026-02-28
COMPANY REGISTRATION NUMBER: 11821066

DIGIMAX DERMA LTD

Filleted Unaudited Financial Statements

28 February 2026

DIGIMAX DERMA LTD

Statement of Financial Position

28 February 2026

| 2026 | 2025
| £ | £
Current assets | 28,708 | 117,571

Creditors: amounts falling due within one year | 53,893 | 84,790
| -------- | ---------
Net current (liabilities)/assets | ( 25,185) | 32,781
| -------- | --------
Total assets less current liabilities | ( 25,185) | 32,781

Accruals and deferred income | – | 800
| -------- | --------
| (25,185) | 31,981
| -------- | --------

Capital and reserves | ( 25,185) | 31,981
| -------- | --------

Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to Nil (2025: Nil).
For the year ending 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 4 August 2026 , and are signed on behalf of the board by:

Mr Shehzad MEMON |
Director |

Company registration number: 11821066
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Digimax Derma, 113 Crawford Street, London, W1H 2JG.